The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension (Q34396612)

1 August 2017

title

The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension (English)

1 reference

postmenopausal osteoporosis

1 August 2017

0 references

1 reference

13

Eric Vittinghoff

0 references

Nathalie Franchimont

17

object named as

Nathalie Franchimont

0 references

Jean-Yves Reginster

9

object named as

Jean-Yves Reginster

1 reference

1 August 2017

7

Dan Mellström

1 reference

1 August 2017

2

Roland Chapurlat

1 reference

1 August 2017

Henry G Bone

1

1 reference

1 August 2017

Maria-Luisa Brandi

3

1 reference

1 August 2017

Jacques P Brown

4

1 reference

1 August 2017

Edward Czerwinski

5

1 reference

1 August 2017

Marc-Antoine Krieg

6

1 reference

1 August 2017

Sebastião C Radominski

8

1 reference

1 August 2017

Heinrich Resch

10

1 reference

1 August 2017

Jose A Román Ivorra

11

1 reference

1 August 2017

Christian Roux

12

1 reference

1 August 2017

Nadia S Daizadeh

14

1 reference

1 August 2017

Andrea Wang

15

1 reference

1 August 2017

Michelle N Bradley

16

1 reference

1 August 2017

Nathalie Franchimont

17

1 reference

1 August 2017

Michelle L Geller

18

1 reference

1 August 2017

Rachel B Wagman

19

1 reference

1 August 2017

Steven R Cummings

20

1 reference

1 August 2017

Socrates Papapoulos

21

1 reference

1 August 2017

language of work or name

English

0 references

publication date

26 August 2013

1 reference

The Journal of Clinical Endocrinology and Metabolism

1 August 2017

published in

1 reference

1 August 2017

volume

98

1 reference

1 August 2017

issue

11

1 reference

1 August 2017

page(s)

4483-4492

1 reference

Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

Denosumab and bisphosphonates: different mechanisms of action and effects.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

Bone quality--the material and structural basis of bone strength and fragility

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

Denosumab in postmenopausal women with low bone mineral density

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

Osteoclast differentiation and activation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

Vertebral fracture assessment using a semiquantitative technique.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

Estimating long-term effects of treatment from placebo-controlled trials with an extension period, using virtual twins

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

Ten years' experience with alendronate for osteoporosis in postmenopausal women

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207950

27 October 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/23979955

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Safety of denosumab in giant-cell tumour of bone

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23979955

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1210/JC.2013-1597

1 reference

1 August 2017

1 reference

1 August 2017

1 reference